Meet the Pharmidex team at 8th international Symposium on Microdialysis
July 25, 2016

Meet the Pharmidex team at 8th international Symposium on Microdialysis, the event will take place on May 25th to the 27th 2016. Psykiatrins Hus, Uppsala, Sweden

The 8th International Symposium on Microdialysis, to be held in Uppsala, Sweden, follows on the 7th Symposium in Poitiers, France. We welcome scientists from academia, industry and regulatory agencies for integrated discussions and exchange of experiences concerning microdialysis from three perspectives: preclinical, clinical and analytical. In the history of these microdialysis symposia there has always been a focus on quantitative aspects of the technique.


 An important goal with the meeting is thematic sessions with interactions between the different subareas to stimulate translational progress. Important development is being made regarding analytical aspects of microdialysis, as well as regarding material development, allowing for new applications. Clinical microdialysis issues related to chemical monitoring of patients in the neurointensive care setting will also be an important focus at the meeting. Recent developments in the area will be presented by scientists from all-over the world.


For more information please see the link: http://www.delegia.com/app/attendee/default.asp?ProjectId=6879&PageId=40598

Funding Opportunity for Early-Stage Innovators in Scotland

May 1, 2026
Early-stage innovators based in Scotland have access to a significant opportunity to advance their programs toward ProofOfConcept, with an additional £2.85M fund from the Scottish Government aimed at supporting early development and enabling further investment. 🗓️ Deadline: 8th May At Pharmidex , we work alongside our partners to generate robust, translational data that supports confident decision-making across early discovery and preclinical development. Our capabilities include: TargetExpression ModeOfActionStudies TargetEngagement HitIdentification ADME and PK profiling If you are preparing an application and require scientific input or timely quotations, we would be pleased to support your programme. 🔗 https://lnkd.in/eZ6vVjgN

We’re pleased to introduce the Pharmidex Senior Management Team

April 29, 2026
We’re pleased to introduce the Pharmidex Senior Management Team (SMT), bringing together expertise across drug discovery, bioanalysis, DMPK, and translational science: 🔹 Alix Hampson 🔹 Dr Mansoor Chishty 🔹 Prof Mo Alavijeh (FRSC, FRSM) 🔹 Dr Martin Barrett 🔹 Dr Stephen Mitchell 🔹 Ash Alavijeh Collectively, the team brings 150+ years of combined experience, supporting programmes from discovery through to the clinic and beyond. We’ve also seen firsthand how similar pieces, in the hands of our 400+ innovative clients, can be combined to unlock real impact for patients. To mark the occasion, we’ve reimagined our SMT in LEGO style 🧱 Much like LEGO: • Great things are built step by step • Every piece has a purpose • The best outcomes come from creativity, collaboration, and continuous evolution At Pharmidex, it’s about bringing the right pieces together, to build smarter solutions and better outcomes.

Tailored Genetically Altered Breeding Solutions at Pharmidex

April 27, 2026
The success of your research starts with the right model, at the right time. At Pharmidex, we deliver tailored GA breeding solutions combining expert colony management, flexible study design, and rigorous quality control. Backed by AAALAC-accredited facilities and a strong commitment to the 3Rs, we ensure reliable, study-ready models with full traceability. From breeding strategy and genotyping to scalable capacity and flexible timelines, we act as an extension of your team, helping accelerate your research with confidence. 🔬 The right models. When you need them. 🚀 Flexible. Reliable. Research-focused. Let’s build your next breeding strategy.
More Posts